Table 7.
Effect of LI12542F6 supplementation on the hematology and serum clinical chemistry parameters of the participants
Parameters | Evaluations | Placebo (n = 20) | LI12542F6 (n = 20) | |
---|---|---|---|---|
Hematology | Hemoglobin (g/dL) | Screening | 14.52 ± 0.82 | 14.66 ± 0.94 |
Day 56 | 14.69 ± 0.96 | 14.74 ± 0.85 | ||
Platelet count (105/μL) | Screening | 2.70 ± 0.64 | 2.33 ± 0.57 | |
Day 56 | 2.69 ± 0.59 | 2.55 ± 0.41 | ||
Red blood cell (106/μL) | Screening | 5.59 ± 0.75 | 5.38 ± 0.35 | |
Day 56 | 5.39 ± 0.37 | 5.18 ± 0.36 | ||
Total white blood cells (/μL) | Screening | 7,040 ± 1,377 | 7,580 ± 1,278 | |
Day 56 | 7,520 ± 1,586 | 7,345 ± 1,414 | ||
Neutrophils (%) | Screening | 61.95 ± 6.43 | 62.95 ± 7.00 | |
Day 56 | 69.0 5 ± 6.21* | 62.40 ± 5.94# | ||
Lymphocytes (%) | Screening | 31.45 ± 5.97 | 30.10 ± 6.50 | |
Day 56 | 24.85 ± 4.79* | 31.60 ± 5.76# | ||
Eosinophil (%) | Screening | 2.8 5 ± 1.81 | 3.20 ± 1.94 | |
Day 56 | 3.50 ± 2.48 | 2.80 ± 1.20 | ||
Monocytes (%) | Screening | 3.80 ± 0.52 | 3.75 ± 0.55 | |
Day 56 | 3.00 ± 1.38* | 3.15 ± 1.04* | ||
Basophils (%) | Screening | 0.00 ± 0.00 | 0.00 ± 0.00 | |
Day 56 | 0.00 ± 0.00 | 0.05 ± 0.22 | ||
Serum clinical chemistry | Fasting glucose (mg/dL) | Screening | 73.75 ± 7.75 | 78.55 ± 7.34 |
Day 56 | 88.25 ± 7.98* | 88.40 ± 8.41* | ||
Creatinine (mg/dL) | Screening | 0.76 ± 0.14 | 0.77 ± 0.12 | |
Day 56 | 0.85 ± 0.11* | 0.89 ± 0.11* | ||
Blood urea nitrogen (mg/dL) | Screening | 10.10 ± 2.88 | 10.20 ± 2.76 | |
Day 56 | 10.40 ± 2.72 | 11.05 ± 2.87 | ||
Bilirubin (mg/dL) | Screening | 0.65 ± 0.34 | 0.58 ± 0.17 | |
Day 56 | 0.70 ± 0.28 | 0.66 ± 0.23 | ||
Aspartate transaminase (U/L) | Screening | 29.05 ± 7.20 | 27.50 ± 8.82 | |
Day 56 | 27.35 ± 6.96 | 26.00 ± 5.86 | ||
Alanine transaminase (U/L) | Screening | 27.75 ± 6.38 | 29.85 ± 11.73 | |
Day 56 | 28.45 ± 10.22 | 25.55 ± 8.70* | ||
Alkaline phosphate (IU/L) | Screening | 85.90 ± 16.68 | 86.25 ± 20.90 | |
Day 56 | 91.20 ± 17.29 | 86.30 ± 16.57 | ||
Sodium (mEq/L) | Screening | 139.60 ± 2.46 | 139.15 ± 1.09 | |
Day 56 | 140.15 ± 2.16 | 139.30 ± 1.75 | ||
Potassium (mEq/L) | Screening | 4.22 ± 0.25 | 4.22 ± 0.18 | |
Day 56 | 4.26 ± 0.22 | 4.23 ± 0.23 | ||
Albumin (g/dL) | Screening | 4.33 ± 0.24 | 4.35 ± 0.17 | |
Day 56 | 4.42 ± 0.19 | 4.46 ± 0.25 | ||
Low-density lipoprotein (mg/dL) | Screening | 82.00 ± 21.68 | 86.90 ± 29.54 | |
Day 56 | 85.80 ± 21.90 | 89.20 ± 24.90 | ||
High-density lipoprotein (mg/dL) | Screening | 37.90 ± 7.95 | 42.85 ± 7.27# | |
Day 56 | 39.80 ± 9.56* | 41.55 ± 7.13 | ||
Very low-density lipoprotein (mg/dL) | Screening | 23.40 ± 11.00 | 21.95 ± 9.56 | |
Day 56 | 27.00 ± 13.67 | 27.00 ± 12.75* | ||
Triglyceride (mg/dL) | Screening | 118.30 ± 54.32 | 111.30 ± 47.68 | |
Day 56 | 133.50 ± 64.84 | 135.75 ± 64.32* | ||
Total cholesterol (mg/dL) | Screening | 143.30 ± 24.88 | 151.70 ± 35.23 | |
Day 56 | 152.60 ± 25.65* | 157.75 ± 30.89 |
Data present the mean ± SD.
and
indicate significance (P < 0.05) in intragroup comparison (vs. baseline) and between-the-groups comparison (vs. placebo), respectively, analyzed using student t-test.